{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00531",
      "entity_text" : "death",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4091",
      "entity_text" : "metformin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Moreover, in the subgroup analysis, the use of metformin reduced the risk of death in patients with localized RCC patients [HR (95% CI) 0.476 (0.295-0.768), I 2 = 12.30%, P heterogeneity = 0.331; Z = 3.04; P = 0.002, Fig. XREF_FIG b].",
  "reading_complete" : "2020-08-05T20:20:24Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:14:02Z",
  "trigger" : "reduced",
  "evidence" : [ "metformin reduced the risk of death" ],
  "pmc_id" : "5443884",
  "score" : 0
}